SERPINB3 in the Chicken Model of Ovarian Cancer: A Prognostic Factor for Platinum Resistance and Survival in Patients with Epithelial Ovarian Cancer

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Lim, Whasun ^a   Kim, Hee Seung ^b   Jeong, Wooyoung ^a   Ahn, Suzie E ^a   Kim, Jinyoung ^a   Kim, Yong Beom ^c   Kim, Min A ^b   Kim, Mi Kyung ^b   Chung, Hyun Hoon ^b   Song, Yong Sang ^a,b   Bazer, Fuller W ^a,d   Han, Jae Yong ^a   Song, Gwonhwa ^a  

^a Seoul National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 101; MICRORNA 1668; MICRORNA 1681; PLATINUM; PROTEIN; SERINE PROTEINASE INHIBITOR; SERPINB3 PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; FEMALE; GENE; HAZARD RATIO; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; OVARY CANCER; OVARY CARCINOMA; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; SERPINB3 GENE; SQUAMOUS CELL CARCINOMA;

3' UNTRANSLATED REGIONS; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHICKENS; DISEASE MODELS, ANIMAL; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARY; PLATINUM; PROGNOSIS; SERINE PROTEINASE INHIBITORS; SERPINS;

ANIMALIA; GALLUS GALLUS;

EID: 84869851878     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049869     Document Type: Article

References (37)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Suh DH, Kim K, Kim JW, (2012) Major clinical research advances in gynecologic cancer in 2011. J Gynecol Oncol 23: 53-64.
3. Kim HS, Kim JW, Cho JY, Chung HH, Park NH, et al. (2009) The role of serum CA-125 levels in early-stage epithelial ovarian cancer on preoperative CT and MRI. Eur J Surg Oncol 35: 870-876.
4. Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, et al. (2006) Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95 (Suppl 1):: S161-192.
5. Pignata S, Cannella L, Leopardo D, Pisano C, Bruni GS, et al. (2011) Chemotherapy in epithelial ovarian cancer. Cancer Lett 303: 73-83.
6. Barua A, Bitterman P, Abramowicz JS, Dirks AL, Bahr JM, et al. (2009) Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int J Gynecol Cancer 19: 531-539.
7. Vanderhyden BC, Shaw TJ, Ethier JF, (2003) Animal models of ovarian cancer. Reprod Biol Endocrinol 1: 67.
8. Stakleff KD, Von Gruenigen VE, (2003) Rodent models for ovarian cancer research. Int J Gynecol Cancer 13: 405-412.
9. Stammer K, Edassery SL, Barua A, Bitterman P, Bahr JM, et al. (2008) Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer. Gynecol Oncol 109: 115-121.
10. Gettins PG, (2002) Serpin structure, mechanism, and function. Chem Rev 102: 4751-4804.
11. Suminami Y, Kishi F, Sekiguchi K, Kato H, (1991) Squamous cell carcinoma antigen is a new member of the serine protease inhibitors. Biochem Biophys Res Commun 181: 51-58.
12. Kato H, Torigoe T, (1977) Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 40: 1621-1628.
13. Schick C, Pemberton PA, Shi GP, Kamachi Y, Cataltepe S, et al. (1998) Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis. Biochemistry 37: 5258-5266.
14. Lim W, Ahn SE, Jeong W, Kim J, Kim J, et al. (2011) Tissue Specific Expression and Estrogen Regulation of SERPINB3 in the Chicken Oviduct. Gen Comp Endocrinol (in press).
15. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM, (2006) MicroRNA expression and function in cancer. Trends Mol Med 12: 580-587.
16. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
17. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R, (2005) Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 123: 631-640.
18. Rodriguez-Burford C, Barnes MN, Berry W, Partridge EE, Grizzle WE, (2001) Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecol Oncol 81: 373-379.
19. Jackson E, Anderson K, Ashwell C, Petitte J, Mozdziak PE, (2007) CA125 expression in spontaneous ovarian adenocarcinomas from laying hens. Gynecol Oncol 104: 192-198.
20. Vidalino L, Doria A, Quarta S, Zen M, Gatta A, et al. (2009) SERPINB3, apoptosis and autoimmunity. Autoimmun Rev 9: 108-112.
21. Kato H, (1996) Expression and function of squamous cell carcinoma antigen. Anticancer Research 16: 2149-2153.
22. Suminami Y, Nagashima S, Murakami A, Nawata S, Gondo T, et al. (2001) Suppression of a squamous cell carcinoma (SCC)-related serpin, SCC antigen, inhibits tumor growth with increased intratumor infiltration of natural killer cells. Cancer Res 61: 1776-1780.
23. Quarta S, Vidalino L, Turato C, Ruvoletto M, Calabrese F, et al. (2010) SERPINB3 induces epithelial-mesenchymal transition. J Pathol 221: 343-356.
24. Castino R, Peracchio C, Salini A, Nicotra G, Trincheri NF, et al. (2009) Chemotherapy drug response in ovarian cancer cells strictly depends on a cathepsin D-Bax activation loop. J Cell Mol Med 13: 1096-1109.
25. Suminami Y, Nagashima S, Vujanovic NL, Hirabayashi K, Kato H, et al. (2000) Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1. Br J Cancer 82: 981-989.
26. Collie-Duguid ES, Sweeney K, Stewart KN, Miller ID, Smyth E, et al. (2011) SerpinB3, a new prognostic tool in breast cancer patients treated with neoadjuvant chemotherapy. Breast Cancer Res Treat.
27. Chechlinska M, Kowalewska M, Brzoska-Wojtowicz E, Radziszewski J, Ptaszynski K, et al. (2010) Squamous cell carcinoma antigen 1 and 2 expression in cultured normal peripheral blood mononuclear cells and in vulvar squamous cell carcinoma. Tumour Biol 31: 559-567.
28. Shiiba M, Nomura H, Shinozuka K, Saito K, Kouzu Y, et al. (2010) Down-regulated expression of SERPIN genes located on chromosome 18q21 in oral squamous cell carcinomas. Oncol Rep 24: 241-249.
29. Hsu KF, Huang SC, Shiau AL, Cheng YM, Shen MR, et al. (2007) Increased expression level of squamous cell carcinoma antigen 2 and 1 ratio is associated with poor prognosis in early-stage uterine cervical cancer. Int J Gynecol Cancer 17: 174-181.
30. Nakashima T, Yasumatsu R, Kuratomi Y, Masuda M, Kuwano T, et al. (2006) Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma. Head Neck 28: 24-30.
31. Petty RD, Kerr KM, Murray GI, Nicolson MC, Rooney PH, et al. (2006) Tumor transcriptome reveals the predictive and prognostic impact of lysosomal protease inhibitors in non-small-cell lung cancer. J Clin Oncol 24: 1729-1744.
32. Song G, Bazer FW, Spencer TE, (2007) Pregnancy and interferon tau regulate RSAD2 and IFIH1 expression in the ovine uterus. Reproduction 133: 285-295.
33. Song G, Spencer TE, Bazer FW, (2006) Progesterone and interferon-tau regulate cystatin C in the endometrium. Endocrinology 147: 3478-3483.
34. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
35. Ahn SE, Choi JW, Rengaraj D, Seo HW, Lim W, et al. (2010) Increased expression of cysteine cathepsins in ovarian tissue from chickens with ovarian cancer. Reprod Biol Endocrinol 8: 100.
36. Shepherd TG, Theriault BL, Campbell EJ, Nachtigal MW, (2006) Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients. Nat Protoc 1: 2643-2649.
37. Giles JR, Olson LM, Johnson PA, (2006) Characterization of ovarian surface epithelial cells from the hen: a unique model for ovarian cancer. Exp Biol Med (Maywood) 231: 1718-1725.